| 31 |
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
|
2020 |
| 32 |
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
|
2020 |
| 33 |
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
|
2020 |
| 34 |
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
|
2020 |
| 35 |
SDDF 2020 |
2020 |
| 36 |
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study |
2019 |
| 37 |
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study |
2019 |
| 38 |
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study |
2019 |
| 39 |
Assessment of physicians adherence to the guidelines for the management of gastroesophageal varices among patients with liver cirrhosis in upper Egypt |
2019 |
| 40 |
Clinical value of presepsin in comparison to hsCRP as a monitoring and early prognostic marker for sepsis in critically ill patients |
2019 |
هل لديك سؤال ؟
